top of page

Saving lives by detecting cardiac electrical defects

acoro-chest.png
acoro-device-full.jpg

AcoroScan

Addressing a global healthcare priority that results in 6 million deaths annually. 

In a fast, non-invasive test, AcoroScan measures the tiny magnetic field generated by the heart to reveal hidden cardiac electrical defects that can lead to fatal ventricular arrhythmias.

Deployable at scale in standard clinical settings, AcoroScan provides clinicians with a powerful new point of care tool to guide those at risk of sudden cardiac death to life-saving treatments. 

A new standard for assessing the risk of sudden cardiac death 

Implantable cardioverter defibrillators (ICD) are effective at preventing sudden cardiac death, but…

80%

of those fitted with an ICD do not need one

80%

of those who would benefit do not receive one

Leading to 300k avoidable deaths and >$20bn of wasted healthcare spend every year.

Source: Acoro, 2025 and references therein  “Scale of aSCD challenge and limitations of current ICD targeting methods” – available on request  

Routine adoption of AcoroScan for assessing risk of SCD in cardiac patients could:

Increase access to ICDs and save 

35,000

additional lives annually

Reduce ineffective ICD implants and save

$6.4BN

in healthcare costs annually

Source: Acoro, 2025 and references therein “Modelling of clinical and financial impact of introducing AcoroScan MCG aSCD risk stratification to guide ICD implantation” – available on request  

SCD risk marker validated in pilot clinical study

Proprietary AcoroScan risk-marker was significantly correlated to a future arrhythmic event. 
 
Offers the potential to reduce ineffective ICD implants by 50% compared to current clinical guidance.

ICD Shock vs Acoro SCD risk score

AUC 0.814 / 0.809

Results from Magneto-SCD trial – publication in progress

Trial protocol: Lachlan T, et al. BMJ Open 2020;10:e038804. doi:10.1136/bmjopen-2020-038804

Point of care assessment for SCD risk

AcoroScan provides an actionable SCD risk score from a 5-minute scan within cardiac care environments.


High patient throughput supports site subscription or fee-per-scan pricing.

Additional Clinical Risk Factors

dial.png
pointer.png

ACORO
aSCD Risk Score

AcoroScan
aSCD Biomarker

Our Company

Acoro Limited is a medical device spin-out company from Leeds University, UK with a vision to transform care for those at risk of sudden cardiac death.

Following compelling performance from a pilot clinical study, we’re working tirelessly to make routine assessment of electrical heart defects a reality. 

Our Core Team

Dr. David Brooks

Dr. David Brooks

CEO

30 years experience in device, diagnostic & drug development, fundraising both private & public. Numerous exits including a diagnostic company to KKR.


Dr. Neil Loxley

Dr. Neil Loxley

CHAIR

30 years experience in funding and growth of VC-backed MedTech and technology businesses as CEO, Chairman and NED.

Dr. Simon Webster

Dr. Simon Webster

NED

25 years of technology development and commercialisation targeting healthcare markets.

Clinical Advisors

Prof. Faizel Osman

Prof. Faizel Osman

CHIEF CLINICAL ADVISOR

Consultant Cardiologist/Electrophysiologist at University Hospitals Coventry and Warwickshire (UHCW) NHS Trust and Honorary Professor of Cardiology at Warwick University medical school. 


Research interests in arrhythmia and sudden cardiac death prediction. Principle investigator of the Magneto-SCD trial.

Dr. Tom Lachlan

Dr. Tom Lachlan

CLINICAL ADVISOR

Fellow in Cardiology at UHCW NHS Trust. 


Trained in Cardiology with speciality training in electrophysiology and devices. Completed PhD demonstrating the predicative ability of room temperature MCG parameters in predicting future ICD shocks.


Dr. Kim Rajappan

Dr. Kim Rajappan

CLINICAL ADVISOR

Consultant Cardiologist & Electrophysiologist at John Radcliffe Hospital, Oxford University Hospitals NHS Foundation Trust.


Specialist in cardiac electrophysiology and treatment of a wide range of conditions associated with heart rhythm

Latest News

Connect with us on LinkedIn for all our latest company news.

Get in touch

ACORO Medical Limited

Nexus, Leeds, LS2 3AA, UK

Registered in England No. 15031679

bottom of page